NCT00791258 - A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure | Biotech Hunter

Enrollment

999

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

September 30, 2009

Conditions

Hypertension

Interventions

DRUG

amlodipine and olmesartan medoxomil tablets

amlodipine and olmesartan medoxomil tablets administered orally, once daily for up to 20 weeks

DRUG

hydrochlorothiazide tablets

hydrochlorothiazide tablets may be administered orally, if necessary once daily, for up to 8 weeks

Trial Locations (72)

Unknown

Birmingham

Green Valley

Mesa

Sierra Vista

Tempe

Tucson

Anaheim

Harbor City

National City

Tustin

Westlake Village

Colorado Springs

Pueblo

Milford

Boynton Beach

Brooksville

Clearwater

Deerfield Beach

DeLand

Fort Lauderdale

Kissimmee

Pembroke Pines

Sarasota

St. Petersburg

Tampa

Boise

Addison

Orland Park

Wichita

Lexington

Columbia

Elkridge

Oxon Hill

Reisterstown

Stevensville

Omaha

Las Vegas

Edison

Sewell

Albuquerque

Binghamton

Cary

Charlotte

Harrisburg

Hickory

High Point

Raleigh

Wilmington

Winston-Salem

Cincinnati

Cleveland

Norman

Oklahoma City

Tulsa

Eugene

Portland

Havertown

Jenkintown

Pittsburgh

Greenville

Mt. Pleasant

New Tazewell

Amarillo

Austin

Carrollton

Corpus Christi

Dallas

Longview

West Jordan

Norfolk

Walla Walla

Madison